TheEdgeResearch
Home / Stocks / XLY.TO

Auxly Cannabis Group Inc. (XLY.TO)

TSX Healthcare Drug Manufacturers - Specialty & Generic
$3.17 ▼ -0.63%
Market Cap
$321.2M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.19
52-Wk Range
1.54-3.3
CEO
Hugo Alves
Country
CA
Currency
CAD

Auxly Cannabis Group Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $3.17, down 0.63% on the session, giving a market capitalisation of $321.2M. Its beta of 1.19 implies it has historically moved more than the broad market.

Company profile
Exchange
Toronto Stock Exchange
Employees
446
IPO date
2018-06-08
Headquarters
Toronto, ON, CA
About Auxly Cannabis Group Inc.

Auxly Cannabis Group Inc. operates as a Canadian consumer packaged goods (CPG) firm focused on the cannabis market. Its primary activities include the development, manufacturing, and distribution of cannabis products, targeting both recreational and wellness consumers. The company offers a wide array of cannabis formats under its distinct brands—KOLAB PROJECT, Dosecann, BACK FORTY, and Foray—including vape cartridges, dried flower, concentrates, chocolates, soft chews, oil drops, capsules, topicals, and hard candy. Originally incorporated in 1987, the company was known as Cannabis Wheaton Income Corp. before officially changing its name to Auxly Cannabis Group Inc. in June 2018. It is headquartered in Toronto, Canada.

Comparable companies

Auxly Cannabis Group Inc. is most often compared with the following Healthcare names:

CRDL.TOCRRX.TOCYBN.NEDB.VGRIN.CNHLS.TOJUSH.CNLOVE.VNGEN.VRX.V
More research on XLY.TO
XLY.TO technical analysis XLY.TO TheEdge Score Compare against peers
Open full interactive analysis & DCF →